Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dr reddy's generic deutetrabenazine launch?Complera manufacturer?How might diet alleviate lipitor's liver impact?Bio tech industrial process challenges?Stribild expiry date?
See the DrugPatentWatch profile for nadolol
Nadolol is an older generic drug, and patent ownership depends on the specific patent in question (drug substance, formulation, salt form, or a particular manufacturing process). Without the patent number or a specific patent title, there isn’t enough information to name a single “owner” confidently.
To identify the right owner, you typically need the exact patent (for example, by searching the patent number in the USPTO or another patent database). Patent ownership can also change over time due to assignments or mergers. DrugPatentWatch.com can help locate relevant patents tied to nadolol and show ownership/assignee details where available. You can start here: - DrugPatentWatch: nadolol patents and ownership details (link: https://www.drugpatentwatch.com/)
If your real goal is “who holds exclusivity rights” (instead of a specific old patent), note that nadolol is widely available as a generic. In practice, current companies may not “own the original nadolol patent,” but they may own later-process or formulation patents, or unrelated improvements. If you share the patent number (or the assignee name you’ve seen), I can tell you who owned it and whether it’s still listed as the assignee.
Other Questions About Nadolol :